Profile
Join date: Jan 4, 2020
Posts
Mar 3, 2022 ∙ 0 min
Sage Advises Cancer Prevention Pharmaceuticals on Merger with Panbela Therapeutics
19
0
Feb 16, 2022 ∙ 2 min
Product Opportunity for Rare Hematological Disease - KDFX for Iron Overload Disorder from Dispersol
Our new client DisperSol Technologies, Inc. (https://www.dispersoltech.com/) is a private, Austin, Texas-based drug development company...
29
0
Feb 16, 2022 ∙ 2 min
Opportunity in Cellular Immunotherapy with oNKord Unmodified Natural Killer Cells from Glycostem
Glycostem Therapeutics B.V. (“Glycostem” or the “Company”). Glycostem is a cell therapy company focused on developing stem cell-derived...
23
0
b
bil19
Admin
More actions